This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Schmitt, J. A. J. Articles by Riedel, W. J. Search for Related Content PubMed PubMed Citation Articles by Schmitt, J. A. J. Articles by Riedel, W. J. Social Bookmarking                         What's this?

Non-serotonergic pharmacological profiles and associated cognitive effects of serotonin reuptake inhibitors

Experimental Psychopharmacology Unit, Department of Psychiatry and Neuropsychology (DRT10), Universiteit Maastricht, PO Box 616, 6200 MD Maastricht, The Netherlands; j.schmitt{at}np.unimaas.nl

Monique J. Kruizinga

Wim J. Riedel

Experimental Psychopharmacology Unit, Brain and Behaviour Institute, Universiteit Maastricht, The Netherlands

The current study was carried out to investigate the cognitive effects of two serotonin reuptake inhibitors (SSRIs), sertraline and paroxetine, with special reference to differences in their affinity for other neurotransmitter systems, i.e. anticholinergic activity of paroxetine and putative dopamine reuptake activity of sertraline. The study was conducted according to a double-blind, three-way cross-over design. During three treatment periods of 2 weeks, 24 healthy middle-aged (aged 30–50 years) subjects of both sexes received sertraline (50 mg on days 1–7, 100 mg on days 8–14), paroxetine (20 mg on days 1–7, 40 mg on days 8–14) and placebo. Paroxetine specifically impaired delayed recall in a word learning test at a dose of 20 and 40 mg. Sertraline did not affect word learning but improved performance on a verbal fluency task at a dose of 50 and 100 mg. Neither drug affected performance on a short-term memory scanning task. These subtle but significant changes in cognitive performance can be explained by subtle differences in pharmacological profiles of these SSRIs. The additional anticholinergic effects of paroxetine could account for its induction of long-term memory impairment. Similarly, the additional dopaminergic effects of sertraline could account for its induction of slightly improved verbal fluency. The impairing and facilitating cognitive effects of paroxetine and sertraline, respectively, may be more pronounced in the elderly depressed patient.

Key Words: cognition drug-effects • memory • paroxetine • serotonin-uptake-inhibitor pharmacology • sertraline

Journal of Psychopharmacology, Vol. 15, No. 3, 173-179 (2001)
DOI: 10.1177/026988110101500304


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				J. M. Silver, T. W. McAllister, and D. B. Arciniegas Depression and Cognitive Complaints Following Mild Traumatic Brain Injury Am J Psychiatry, June 1, 2009; 166(6): 653 - 661. [Abstract] [Full Text] [PDF]

				J. M. Ellison A 60-Year-Old Woman With Mild Memory Impairment: Review of Mild Cognitive Impairment JAMA, October 1, 2008; 300(13): 1566 - 1574. [Abstract] [Full Text] [PDF]

				G. Valerius, A. Lumpp, A.-K. Kuelz, T. Freyer, and U. Voderholzer Reversal Learning as a Neuropsychological Indicator for the Neuropathology of Obsessive Compulsive Disorder? A Behavioral Study J Neuropsychiatry Clin Neurosci, May 1, 2008; 20(2): 210 - 218. [Abstract] [Full Text] [PDF]

				C. A. Shively, D. P. Friedman, H. D. Gage, M. C. Bounds, C. Brown-Proctor, J. B. Blair, J. A. Henderson, M. A. Smith, and N. Buchheimer Behavioral Depression and Positron Emission Tomography-Determined Serotonin 1A Receptor Binding Potential in Cynomolgus Monkeys. Arch Gen Psychiatry, April 1, 2006; 63(4): 396 - 403. [Abstract] [Full Text] [PDF]

				W. Wouters-Wesseling, L. W. Wagenaar, M. Rozendaal, J. B. Deijen, L. C. de Groot, J. G. Bindels, and W. A. van Staveren Effect of an Enriched Drink on Cognitive Function in Frail Elderly Persons J. Gerontol. A Biol. Sci. Med. Sci., February 1, 2005; 60(2): 265 - 270. [Abstract] [Full Text] [PDF]

				W. J. Riedel, K. Eikmans, A. Heldens, and J. A. J. Schmitt Specific serotonergic reuptake inhibition impairs vigilance performance acutely and after subchronic treatment J Psychopharmacol, January 1, 2005; 19(1): 12 - 20. [Abstract] [PDF]

				P. M. Doraiswamy, K. R. R. Krishnan, T. Oxman, L. R. Jenkyn, D. J. Coffey, T. Burt, and C. M. Clary Does Antidepressant Therapy Improve Cognition in Elderly Depressed Patients? J. Gerontol. A Biol. Sci. Med. Sci., December 1, 2003; 58(12): M1137 - 1144. [Abstract] [Full Text] [PDF]

				J. D Joss, R. M Burton, and C. A Keller Memory Loss in a Patient Treated with Fluoxetine Ann. Pharmacother., December 1, 2003; 37(12): 1800 - 1803. [Abstract] [Full Text] [PDF]

				J. H. Hughes, P. Gallagher, M. E. Stewart, D. Matthews, T. P. Kelly, and A. H. Young The Effects of Acute Tryptophan Depletion on Neuropsychological Function J Psychopharmacol, September 1, 2003; 17(3): 300 - 309. [Abstract] [PDF]

				R. J. PORTER, P. GALLAGHER, J. M. THOMPSON, and A. H. YOUNG Neurocognitive impairment in drug-free patients with major depressive disorder The British Journal of Psychiatry, March 1, 2003; 182(3): 214 - 220. [Abstract] [Full Text] [PDF]